Roundup: News sparks market mayhem, gamers hate Spore DRM, DoJ eyes Google antitrust case, and more
With both DEMO and TechCrunch 50 going on, there’s almost too much to report. Here are some of the extra bits:
Old news becomes new problem — A six year old article about a United Airlines bankruptcy filing re-appeared on Google News Monday morning, triggering a massive… Continue Reading
Gene expression diagnostic company XDx raises $35.4M more
XDx, the startup behind a test measuring gene activity in the blood, is raising an additional $35.4 million in its fifth round of funding, according to VentureWire.
The Brisbane, Calif. company filed for an IPO of up to $86.3 million back in October, but has reportedly… Continue Reading
XDx marks a spot: An $86M IPO for gene-expression diagnostics
(UPDATED: See below.)
When XDx yesterday filed to raise up to $86.3 million in an IPO, the Brisbane, Calif., company joined just a handful of similar molecular-diagnostic companies to test the public markets. XDx specializes in a new type of diagnostic test that measures gene activity —… Continue Reading
XDx looking to raise $25 million more for personalized medicine
XDx, a Brisbane, Calif. company that monitors the immune system with personalized medicine based on insights from the Human Genome Project, said it is raising up to $25 million more in cash.
The news, reported this morning by VentureWire (sub required) would be the company’s fifth… Continue Reading